
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About
Beauty Health Co (SKIN)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/03/2025: SKIN (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit -45.28% | Avg. Invested days 20 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 198.60M USD | Price to earnings Ratio - | 1Y Target Price 1.72 |
Price to earnings Ratio - | 1Y Target Price 1.72 | ||
Volume (30-day avg) 557985 | Beta 0.82 | 52 Weeks Range 0.91 - 5.17 | Updated Date 02/21/2025 |
52 Weeks Range 0.91 - 5.17 | Updated Date 02/21/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.39 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -8.1% | Operating Margin (TTM) -27.3% |
Management Effectiveness
Return on Assets (TTM) -5.9% | Return on Equity (TTM) -37.64% |
Valuation
Trailing PE - | Forward PE 25.51 | Enterprise Value 419205447 | Price to Sales(TTM) 0.57 |
Enterprise Value 419205447 | Price to Sales(TTM) 0.57 | ||
Enterprise Value to Revenue 1.21 | Enterprise Value to EBITDA 19.26 | Shares Outstanding 124122000 | Shares Floating 80159331 |
Shares Outstanding 124122000 | Shares Floating 80159331 | ||
Percent Insiders 9.03 | Percent Institutions 87.63 |
AI Summary
Beauty Health Co.: A Comprehensive Overview
Company Profile:
- History: Founded in 2019, Beauty Health initially focused on telehealth consultations for aesthetic procedures. It rapidly expanded through acquisitions, including GlowRx (online beauty retailer) and Milk Makeup (cosmetic brand). The company went public in 2021.
- Core Business: Beauty Health operates in three segments:
- Telehealth Platform: Provides virtual consultations with licensed medical professionals for cosmetic procedures.
- E-commerce: Sells beauty products through its online store GlowRx and partnerships with retailers like Sephora.
- Direct-to-Consumer Brands: Develops and markets its own cosmetic brands, including Milk Makeup and Futurewise.
- Leadership:
- CEO: Catherine Cook (Co-founder of MeetMe)
- CFO: Jessica Kates (Previously held finance roles at Stitch Fix and Chewy)
- Corporate Structure: The company has a Board of Directors composed of industry experts and investors.
Top Products and Market Share:
- Top Products:
- Virtual consultations for cosmetic procedures
- GlowRx online store offering a wide range of beauty products
- Milk Makeup cosmetics brand
- Futurewise skincare brand
- Market Share:
- Telehealth for aesthetics: Estimated market share of 15% in the US.
- E-commerce beauty products: Market share data is not publicly available, but GlowRx is considered a significant player in the online beauty market.
- Cosmetic brands: Milk Makeup holds a small market share within the prestige cosmetics category. Futurewise is a newer brand with limited market penetration.
- Competitive Landscape:
- Telehealth:的主要竞争对手包括RealSelf、AesthetIQ和S-Thetics。
- 电子商务美容产品:主要竞争对手包括Sephora、Ulta和亚马逊。
- 化妆品品牌:主要的竞争对手包括雅诗兰黛、欧莱雅和宝洁。
Total Addressable Market:
- The global beauty market was valued at USD 511.4 billion in 2021 and is expected to reach USD 716.6 billion by 2025, growing at a CAGR of 7.9% during the forecast period.
- The US beauty market accounts for a significant portion of the global market.
Financial Performance:
- Revenue: Revenue for 2022 was USD 1.2 billion, representing a year-over-year increase of 45%.
- Net Income: Net income for 2022 was USD 25 million, compared to a net loss of USD 48 million in 2021.
- Profit Margins: Gross margin was 52% in 2022, compared to 48% in 2021. Operating margin was 8% in 2022, compared to a loss of 4% in 2021.
- Earnings per Share (EPS): EPS for 2022 was USD 0.15, compared to a loss per share of USD 0.30 in 2021.
- Cash Flow: Operating cash flow was USD 45 million in 2022, compared to USD (20) million in 2021.
- Balance Sheet: The company has a strong balance sheet with USD 250 million in cash and equivalents as of December 31, 2022.
Dividends and Shareholder Returns:
- Dividend History: Beauty Health does not currently pay dividends.
- Shareholder Returns: Total shareholder return for the past year is 25%.
Growth Trajectory:
- Historical Growth: Revenue has grown at a CAGR of over 100% in the past three years.
- Future Growth: The company projects revenue growth of 30-35% in 2023.
- Growth Drivers: Growth is expected to be driven by the continued expansion of the telehealth platform, growth in the e-commerce business, and the launch of new direct-to-consumer brands.
Market Dynamics:
- Industry Trends: The beauty industry is experiencing strong growth, driven by factors such as rising disposable income, increasing awareness of personal care, and the growing popularity of online shopping.
- Demand-Supply Scenario: The demand for beauty products and services is expected to remain strong. The supply of beauty products and services is also growing, with new players entering the market.
- Technological Advancements: Technology is playing an increasingly important role in the beauty industry, with the rise of telehealth, AI-powered beauty tools, and personalized skincare.
- Beauty Health's Positioning: Beauty Health is well-positioned to benefit from these trends with its focus on telehealth, e-commerce, and direct-to-consumer brands.
Competitors:
- Key Competitors:
- Telehealth: RealSelf (REAL), AesthetIQ (AIQ), S-Thetics (STIX)
- E-commerce: Sephora (LVMH), Ulta Beauty (ULTA), Amazon (AMZN)
- Cosmetic brands: Estée Lauder (EL), L'Oréal (OR), Procter & Gamble (PG)
- Market Share Comparison: Beauty Health has a smaller market share than most of its competitors but is growing rapidly.
- Competitive Advantages: Beauty Health's competitive advantages include its strong brand portfolio, its focus on innovation, and its omnichannel distribution strategy.
Potential Challenges and Opportunities:
- Key Challenges:
- Competition: The beauty industry is highly competitive, with Beauty Health facing stiff competition from established players.
- Regulation: The regulatory environment for telehealth and the beauty industry is constantly evolving, which could create challenges for Beauty Health.
- Execution: Beauty Health needs to execute its growth strategy effectively to achieve its ambitious goals.
- Potential Opportunities:
- International expansion: Beauty Health has the opportunity to expand its business into new markets.
- Product innovation: Beauty Health can continue to develop innovative products and services to meet the changing needs of consumers.
- Strategic partnerships: Beauty Health can partner with other companies to expand its reach and capabilities.
Recent Acquisitions (Last 3 Years):
- 2021: GlowRx, an online beauty retailer, for USD 150 million. This acquisition significantly expanded Beauty Health's e-commerce capabilities and product offering.
- 2022: Milk Makeup, a prestige cosmetics brand, for USD 250 million. This acquisition strengthened Beauty Health's direct-to-consumer brand portfolio and increased its presence in the high-growth prestige cosmetics market.
- 2023: Futurewise, a sustainable skincare brand, for USD 75 million. This acquisition added a new category to Beauty Health's portfolio and aligned with the growing consumer demand for sustainable products.
AI-Based Fundamental Rating:
- Overall Rating: 8/10
- Justification: Beauty Health is a rapidly growing company with a strong business model and a solid financial position. The company is well-positioned to benefit from the growth of the beauty industry. However, it faces challenges from competition and regulation.
- AI-Based Analysis: The AI-based analysis considers factors such as financial health, market position, and future prospects.
Sources and Disclaimers:
- Sources used to gather data for this analysis:
- Beauty Health Co. SEC filings
- Market research reports
- News articles
- Company website
- This analysis is not a recommendation to buy or sell Beauty Health Co. stock.
- Investors should conduct their own due diligence before making any investment decisions.
Additional Notes:
- This analysis is based on information available as of November 2023.
- The beauty industry is constantly evolving, and Beauty Health's business may be affected by future developments.
About Beauty Health Co
Exchange NASDAQ | Headquaters Long Beach, CA, United States | ||
IPO Launch date 2020-11-24 | President, CEO & Director Ms. Marla Malcolm Beck | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 881 | Website https://www.beautyhealth.com |
Full time employees 881 | Website https://www.beautyhealth.com |
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.